Rami S. Komrokji

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes”.

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Blood Advances(2023)10.1182/bloodadvances.2022009000

N/A

0.697DataRank · unranked

16 citations

Donnie Hebert, Cecilia Lee, Dana E. Rollison, Nancy Gillis, Rami S. Komrokji +15 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Blood Cancer Journal(2021)10.1038/s41408-021-00446-y

N/A

0DataRank · unranked

10 citations

Guillermo Montalban‐Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour +26 more

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood Cancer Journal(2022)10.1038/s41408-022-00622-8

N/A

0DataRank · unranked

20 citations

Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al‐Kali +10 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.01.514753

N/A

0DataRank · unranked

0 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +19 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Considerations for Drug Development in Myelodysplastic Syndromes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3348

N/A

0DataRank · unranked

12 citations

Nina Kim, Amy E. DeZern, Kelly J. Norsworthy, Jacqueline S. Garcia, R. Angelo de Claro +6 more

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3929

N/A

0DataRank · unranked

5 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +20 more

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

Leukemia Research(2023)10.1016/j.leukres.2023.107340

N/A

0DataRank · unranked

2 citations

David M. Swoboda, Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard +4 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Advancing drug development in myelodysplastic syndromes

Blood Advances(2024)10.1182/bloodadvances.2024014865

N/A

0DataRank · unranked

12 citations

Kathy L. McGraw, Lea Cunningham, Nina Kim, Emily Y. Jen, Katherine R. Calvo +17 more

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study

Blood Neoplasia(2024)10.1016/j.bneo.2024.100026

N/A

0DataRank · unranked

1 citations

Johannes B. Goll, Travis L. Jensen, Sridhar Nonavinkere Srivatsan, Nancy Gillis, Gregory A. Abel +14 more

An integrative review of cancer-related cachexia and sarcopenia: A different focus in malignant hematology

Health Sciences Review(2024)10.1016/j.hsr.2024.100205

N/A

0DataRank · unranked

3 citations

Tina M. Mason, Rami S. Komrokji, Sara Tinsley

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers

Advances in Hematology(2025)10.1155/ah/9924808

N/A

0DataRank · unranked

2 citations

Andre Hejazi, Vonetta L. Williams, Craig Comperatore, Srinivas K. Tantravahi, Najla Al Ali +14 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes

Journal of Clinical Investigation(2020)10.1172/jci133678

N/A

0DataRank · unranked

56 citations

Rajasekhar N.V.S. Suragani, Srinivas Aluri, Nishi Shah, Tushar D. Bhagat, Mark J. Alexander +3 more